Corcept Therapeutics Incorporated (CORT): Price and Financial Metrics
CORT Price/Volume Stats
Current price | $22.95 | 52-week high | $34.28 |
Prev. close | $22.66 | 52-week low | $20.87 |
Day low | $22.56 | Volume | 924,700 |
Day high | $23.03 | Avg. volume | 1,445,296 |
50-day MA | $23.88 | Dividend yield | N/A |
200-day MA | $26.57 | Market Cap | 2.38B |
CORT Stock Price Chart Interactive Chart >
Corcept Therapeutics Incorporated (CORT) Company Bio
Corcept Therapeutics engages in the discovery, development, and commercialization of drugs for the treatment of metabolic, oncologic, and psychiatric disorders. The company was founded in 1998 and is based in Menlo Park, California.
Latest CORT News From Around the Web
Below are the latest news stories about CORCEPT THERAPEUTICS INC that investors may wish to consider to help them evaluate CORT as an investment opportunity.
Corcept Therapeutics Inc's Chief Development Officer Sells SharesOn December 22, 2023, Chief Development Officer William Guyer sold 10,000 shares of Corcept Therapeutics Inc (NASDAQ:CORT), as reported in a recent SEC Filing. |
Corcept Therapeutics Incorporated (NASDAQ:CORT) Shares Could Be 36% Below Their Intrinsic Value EstimateKey Insights Corcept Therapeutics' estimated fair value is US$41.23 based on 2 Stage Free Cash Flow to Equity Corcept... |
Here's Why Corcept Therapeutics (CORT) is a Strong Momentum StockWhether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service. |
Nektar (NKTR) Up 4% Since Last Earnings Report: Can It Continue?Nektar (NKTR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues. |
Insider Sell: Joseph Lyon of Corcept Therapeutics Inc (CORT) Sells 5,000 SharesJoseph Lyon, the Chief Accounting Officer of Corcept Therapeutics Inc, has recently made a significant stock transaction, selling 5,000 shares of the company on December 4, 2023. |
CORT Price Returns
1-mo | -7.27% |
3-mo | -6.02% |
6-mo | -15.78% |
1-year | 2.18% |
3-year | -0.99% |
5-year | 87.04% |
YTD | -29.34% |
2023 | 59.92% |
2022 | 2.58% |
2021 | -24.31% |
2020 | 116.20% |
2019 | -9.43% |
Continue Researching CORT
Here are a few links from around the web to help you further your research on Corcept Therapeutics Inc's stock as an investment opportunity:Corcept Therapeutics Inc (CORT) Stock Price | Nasdaq
Corcept Therapeutics Inc (CORT) Stock Quote, History and News - Yahoo Finance
Corcept Therapeutics Inc (CORT) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...